An updated guideline for the treatment of Cushing’s disease focuses on new therapeutic options and an algorithm for screening and diagnosis, along with best practices for managing disease ...

DelveInsight's Cushing's Disease Market Insights report includes a comprehensive understanding of current treatment practices, Cushing's disease emerging drugs, market share of individual ...

Algorithm for appropriate use of medical therapy in Cushing's disease. ... Cushing's syndrome is a debilitating disorder which requires rapid reversal of hypercortisolemia to limit morbidity.

The FDA approved the steroidogenesis inhibitor levoketoconazole for adults with Cushing’s syndrome for whom surgery is not an option or has not been curative, according to an industry press release.

References [1] The thrombotic risk in Cushing’s syndrome—questions, answers, and the algorithm to consider in its assessment: part I—thrombotic risk not related to surgery. Frontiers in ...

Introduction. Endogenous Cushing's syndrome is a debilitating endocrine disorder which results from excess circulating cortisol. Eighty percent of the cases are a result of excess ...